Abstract：
BACKGROUND: Postpartum hypertension is a risk factor for severe maternal morbidity; however, barriers exist for diagnosis and treatment. Remote blood pressure (BP) monitoring programs are an effective tool for monitoring BP and may mitigate maternal health disparities. We aimed to describe and evaluate engagement in a remote BP monitoring program on BP ascertainment during the first 6-weeks postpartum among a diverse patient population.
RESULTS: A postpartum remote BP monitoring program, using cell-enabled technology and delivered in multiple languages, was implemented at a large safety-net hospital. Eligible patients are those with hypertensive disorders before or during pregnancy. We describe characteristics of patients enrolled from January 2021 to May 2022 and examine program engagement by patient characteristics. Linear regression models were used to calculate mean differences and 95% CIs between characteristics and engagement metrics. We describe the prevalence of patients with BP ≥140/or >90 mm Hg. Among 1033 patients, BP measures were taken an average of 15.2 days during the 6-weeks, with the last measurement around 1 month (mean: 30.9 days), and little variability across race or ethnicity. Younger maternal age (≤25 years) was associated with less frequent measures (mean difference, -4.3 days [95% CI: -6.1 to -2.4]), and grandmultiparity (≥4 births) was associated with shorter engagement (mean difference, -3.5 days [95% CI, -6.1 to -1.0]). Prevalence of patients with BP ≥140/or >90 mm Hg was 62.3%, with differences by race or ethnicity (Black: 72.9%; Hispanic: 52.4%; White: 56.0%).
CONCLUSIONS: A cell-enabled postpartum remote BP monitoring program was successful in uniformly monitoring BP and capturing hypertension among a diverse, safety-net hospital population.
RESULTS: A postpartum remote BP monitoring program, using cell-enabled technology and delivered in multiple languages, was implemented at a large safety-net hospital. Eligible patients are those with hypertensive disorders before or during pregnancy. We describe characteristics of patients enrolled from January 2021 to May 2022 and examine program engagement by patient characteristics. Linear regression models were used to calculate mean differences and 95% CIs between characteristics and engagement metrics. We describe the prevalence of patients with BP ≥140/or >90 mm Hg. Among 1033 patients, BP measures were taken an average of 15.2 days during the 6-weeks, with the last measurement around 1 month (mean: 30.9 days), and little variability across race or ethnicity. Younger maternal age (≤25 years) was associated with less frequent measures (mean difference, -4.3 days [95% CI: -6.1 to -2.4]), and grandmultiparity (≥4 births) was associated with shorter engagement (mean difference, -3.5 days [95% CI, -6.1 to -1.0]). Prevalence of patients with BP ≥140/or >90 mm Hg was 62.3%, with differences by race or ethnicity (Black: 72.9%; Hispanic: 52.4%; White: 56.0%).
CONCLUSIONS: A cell-enabled postpartum remote BP monitoring program was successful in uniformly monitoring BP and capturing hypertension among a diverse, safety-net hospital population.
摘要：
背景：产后高血压是严重产妇发病率的危险因素；然而，诊断和治疗存在障碍。远程血压（BP）监测计划是监测BP的有效工具，可以减轻孕产妇健康差异。我们旨在描述和评估不同患者人群在产后前6周内对BP确定的远程BP监测计划的参与。
结果：产后远程血压监测计划，使用支持细胞的技术并以多种语言提供，在一家大型安全网医院实施。符合条件的患者是妊娠前或妊娠期间患有高血压疾病的患者。我们描述了2021年1月至2022年5月招募的患者的特征，并根据患者特征检查项目参与度。线性回归模型用于计算特征和参与度指标之间的平均差异和95%CI。我们描述了BP≥140/或>90mmHg的患者的患病率。在1033名患者中，在6周内平均进行了15.2天的血压测量，最后一次测量大约1个月(平均:30.9天)，种族或族裔之间的差异很小。年轻的产妇年龄(≤25岁)与频率较低的测量相关(平均差异，-4.3天[95%CI：-6.1至-2.4])，和多产(≥4个出生)与较短的参与(平均差，-3.5天[95%CI，-6.1至-1.0]）。BP≥140/或>90mmHg患者的患病率为62.3％，种族或民族差异（黑人：72.9％；西班牙裔：52.4％；白人：56.0％）。
结论：一个支持细胞的产后远程血压监测计划成功地在不同的人群中统一监测血压并捕获高血压，安全网医院人口。
结果：产后远程血压监测计划，使用支持细胞的技术并以多种语言提供，在一家大型安全网医院实施。符合条件的患者是妊娠前或妊娠期间患有高血压疾病的患者。我们描述了2021年1月至2022年5月招募的患者的特征，并根据患者特征检查项目参与度。线性回归模型用于计算特征和参与度指标之间的平均差异和95%CI。我们描述了BP≥140/或>90mmHg的患者的患病率。在1033名患者中，在6周内平均进行了15.2天的血压测量，最后一次测量大约1个月(平均:30.9天)，种族或族裔之间的差异很小。年轻的产妇年龄(≤25岁)与频率较低的测量相关(平均差异，-4.3天[95%CI：-6.1至-2.4])，和多产(≥4个出生)与较短的参与(平均差，-3.5天[95%CI，-6.1至-1.0]）。BP≥140/或>90mmHg患者的患病率为62.3％，种族或民族差异（黑人：72.9％；西班牙裔：52.4％；白人：56.0％）。
结论：一个支持细胞的产后远程血压监测计划成功地在不同的人群中统一监测血压并捕获高血压，安全网医院人口。
